具有临床意义的单克隆免疫球蛋白病

张之尧; 耿传营; 陈文明

doi:10.13201/j.issn.1004-2806.2017.07.005

具有临床意义的单克隆免疫球蛋白病

- 首都医科大学附属北京朝阳医院血液科(北京, 100020)

详细信息

通讯作者: 陈文明,E-mail:wenming_chen@yahoo.com

中图分类号: R733.3

收稿日期: 2017-05-26

Monoclonal gammopathy of clinical significance

More Information

Corresponding author: CHEN Wenming, E-mail: wenming_chen@yahoo.com

Received Date: 26 May 2017

摘要

- 有临床意义的单克隆免疫球蛋白病 /
- 诊断 /
- 治疗
- monoclonal gammopathy of clinical significance /
- diagnosis /
- treatment

HTML全文

参考文献(20)

[1]	Sethi S,Fervenza FC,Rajkumar SV.Spectrum of manifestations of monoclonal gammopathy-associated renal lesions[J].Curr Opin Nephrol Hypertens,2016,25:127-137.
[2]	Sayed RH,Wechalekar AD,Gilbertson JA,et al.Natural history and outcome of light chain deposition disease[J].Blood,2015,126:2805-2810.
[3]	Nasr SH,Valeri AM,Cornell LD,et al.Renal monoclonal immunoglobulin deposition disease:a report of 64 patients from a single institution[J].Clin J Am Soc Nephrol,2012,7:231-239.
[4]	Liu Y,Zhu T,Xu L,et al.A single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy[J].Leuk Lymphoma,2015,56:3124-3128.
[5]	Bridoux F,Leung N,Hutchison CA,et al.Diagnosis of monoclonal gammopathy of renal significance[J].Kidney Int,2015,87:698-711.
[6]	Fermand JP,Bridoux F,Kyle RA,et al.How I treat monoclonal gammopathy of renal significance (MGRS)[J].Blood,2013,122:3583-3590.
[7]	Lipsker D.Monoclonal gammopathy of cutaneous significance:review of a relevant concept[J].J Eur Acad Dermatol Venereol,2017,31:45-52.
[8]	Cao XX,Wang T,Liu YH,et al.Successful treatment of scleromyxedema with melphalan and dexamethasone followed by thalidomide maintenance therapy[J].Leuk Lymphoma,2016,57:2934-2936.
[9]	Claes K,Bammens B,Delforge M,et al.Another devastating complication of the Schnitzler syndrome:AA amyloidosis[J].Br J Dermatol,2008,158:182-184.
[10]	Jain T,Offord CP,Kyle RA,et al.Schnitzler syndrome:an under-diagnosed clinical entity[J].Haematologica,2013,98:1581-1585.
[11]	Sykes DB,Schroyens W,O'Connell C.The TEMPI syndrome--a novel multisystem disease[J].N Engl J Med,2011,365:475-477.
[12]	Rongioletti F,Rebora A.Updated classification of papular mucinosis,lichen myxedematosus,and scleromyxedema[J].J Am Acad Dermatol,2001,44:273-281.
[13]	Rongioletti F,Merlo G,Cinotti E,et al.Scleromyxedema:a multicenter study of characteristics,comorbidities,course,and therapy in 30 patients[J].J Am Acad Dermatol,2013,69:66-72.
[14]	Kwok M,Korde N,Landgren O.Bortezomib to treat the TEMPI syndrome[J].N Engl J Med,2012,366:1843-1845.
[15]	Bontscho J,Schreiber A,Manz RA,et al.Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis[J].J Am Soc Nephrol,2011,22:336-348.
[16]	Kenderian SS,Rosado FG,Sykes DB,et al.Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation[J].Leukemia,2015,29:2414-2416.
[17]	Nobile-Orazio E.Neuropathy and monoclonal gammopathy[J].Handb Clin Neurol,2013,115:443-459.
[18]	Talamo G,Mir M A,Pandey MK,et al.IgM MGUS associated with anti-MAG neuropathy:a single institution experience[J].Ann Hematol,2015,94:1011-1016.
[19]	Li J,Zhang W,Jiao L,et al.Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome[J].Blood,2011,117:6445-6449.
[20]	Singh K.Immunotactoid microtubular corneal deposits in bilateral paraprotein crystalline keratopathy[J].Cornea,2009,28:829-831.